4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-16-024380
President and CEO sold 56,789 shares at an average $29.81 ($1,692,705)
- President and CEO acquired 56,789 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pomerantz Roger · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-07-01 | Exercise or conversion : show line 1 in the form | +56,789 | $0.71 | $40,320 | 240,481 | D |
| 2016-07-01 | Sale : show line 2 in the form | −4,832 | $29.12 | $140,708 | 235,649 | D |
| 2016-07-01 | Sale : show line 3 in the form | −41,957 | $29.84 | $1,251,997 | 193,692 | D |
| 2016-07-01 | Sale : show line 4 in the form | −10,000 | $30.00 | $300,000 | 183,692 | D |
| Open-market sales · 56,789 sh · avg $29.81 · $1,692,705 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-07-01 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −56,789 | $0.71 | 2024-08-07 | 56,789 | 1,160,497 | D |
Loading xslF345X03/doc4.xml…